Gan & Lee Pharmaceuticals News and Activities

Gan & Lee Pharmaceuticals is one of the...

• CSI 500;
• TOB Iconic 10,000.

Gan & Lee Pharmaceuticals is a company listed under the stock ticker 603087 (CN).

View the org chart displaying its 12 main executives

Most searched biographies at Gan & Lee Pharmaceuticals

• Haiya Wu, Vice President
• Gary Furda, Chief Operating Officer, USA
• John Wang, Senior Vice President and Chief Strategy Officer

Popular executive movements at Gan & Lee Pharmaceuticals

• Qiang Wang has joined the company as Chief Strategy Officer  (posted on July 8 2026).
• Qi Wang has joined the company as Executive Vice President & Chief Financial Officer  (posted on July 8 2026).
• John Wang has joined the company as Senior Vice President and Chief Strategy Officer  (posted on January 30 2026).

Click here to view some more movements at Gan & Lee Pharmaceuticals

Create your alert
to follow the executive moves at Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Gan & Lee Pharmaceuticals

Social media about Gan & Lee Pharmaceuticals

• Gan & Lee Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Gan & Lee Pharmaceuticals on LinkedIn, X (Twitter) & YouTube